DarioHealth (Nasdaq:DRIO) announced today that it launched a new smart blood sugar meter for Apple iPhone 15 users. The launch of the new technology supports ongoing engagement with new and existing members for the digital health company. DarioHealth said in a news release that the new iPhone 15’s USB-C charging port constitutes a key element […]
DarioHealth Corp
2-year data backs DarioHealth digital diabetes platform
DarioHealth (Nasdaq:DRIO) today announced new research demonstrating sustainably improved outcomes with its digital diabetes platform. New York-based DarioHealth designed its digital health solutions to combine a clinically intelligent platform with consumer insights. It helps to drive sustainable behavior change to improve the management of chronic conditions, including diabetes. Get the full story at our sister […]
Research highlights cost savings from DarioHealth digital diabetes therapeutic
DarioHealth (Nasdaq:DRIO) announced today that a new analysis demonstrated a significant cost reduction for users of its digital therapeutic platform. Sanofi U.S. conducted the analysis, which showed lower costs of care for DarioHealth users compared to non-users with type 2 diabetes. The study used matched claims to show an estimated $5,077 in medical cost savings […]
DarioHealth prices $14.3M offering
DarioHealth (Nasdaq:DRIO) announced today that it priced a private placement of convertible preferred stock at $14.3 million. New York-based DarioHealth received significant participation in the pricing by select members of leadership, the board and existing investors. The company also refinanced its existing credit facility. As a result, the company reports a proforma cash balance as […]
DarioHealth names digital health veteran Eitan Shay as chief product officer
DarioHealth (Nasdaq:DRIO) announced today that it named Eitan Shay to its newly created chief product officer position. Shay’s work history includes leadership roles at digital health companies Livongo and Teladoc Health. He also held senior leadership positions at Meta Platforms. “Demand for our solution continues to accelerate among payers and employers, and the ability to […]
DarioHealth, Dexcom partner to integrate CGM into digital health platform
DarioHealth (Nasdaq:DRIO) announced today that it agreed with Dexcom (Nasdaq:DXCM) to integrate continuous glucose monitoring into its digital health platform. Dexcom CGM uses small, wearable sensors to continuously measure and send glucose levels to a receiver or smart device. The company’s latest CGM technology, the Dexcom G7, recently received FDA clearance. The company plans to […]
7 innovative digital health offerings to treat diabetes
From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]
DarioHealth closes $50M loan facility with OrbiMed
DarioHealth (Nasdaq:DRIO) announced today that it closed a senior secured term loan facility worth up to $50 million. OrbiMed, a leading healthcare investor, will provide non-dilutive capital to fund the continued development of New York-based DarioHealth’s digital health platform for managing chronic diseases, including diabetes. Get the full story at our sister site, Drug Delivery Business News.
The biggest stories from the American Diabetes Association (ADA) 2022 Scientific Sessions
For the 82nd time, the American Diabetes Association (ADA) Scientific Sessions convened to highlight all the innovations within the diabetes technology space. Major players like Dexcom, Medtronic, Abbott and more continue to plug along, while companies like Bigfoot Biomedical, One Drop and others shared data backing the technology that they bring to the table. The […]
Study backs DarioHealth’s digital therapeutics for managing diabetes
DarioHealth (Nasdaq:DRIO) announced today that multiple research studies support its digital therapeutics for diabetes management. New York-based DarioHealth presented the data from the new studies at the American Diabetes Association’s (ADA) 82nd Scientific Sessions in New Orleans. Two of the studies add to DarioHealth’s evidence supporting an integrated approach to managing multiple chronic conditions, while the third […]
DarioHealth rises on Street-beating Q1
DarioHealth (Nasdaq:DRIO) shares ticked up this morning on first-quarter results that beat the consensus forecast. The (LOCATION)-based digital therapeutics company posted losses of $15.9 million, or 74¢ per share, on sales of $8.1 million for the three months ended March 31, 2022, for a bottom-line slide about $1 million deeper into the red despite more […]
